Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways

RCC is a malignant tumor arising from the urothelium of renal parenchyma that remains challenging to be treated. In this study, we assessed the anti-tumor effects of Resveratrol liposomes (RES-lips) combined with sorafenib on renal cell carcinoma (RCC) and explored the potential mechanisms underlyin...

Full description

Bibliographic Details
Published in:	International Journal of Pharmaceutics: X
Main Authors:	Ligang Wang, Ying Wang, Qiqi Xie, Songcheng Xu, Chen Yang, Fei Liu, Yang Liu, Fuwei Wang, Weinan Chen, Jianchun Li, Litao Sun
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	Resveratrol liposomes Sorafenib Resistance Combination Renal cell carcinoma PI3K-AKT-mTOR
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590156724000525

Similar Items

Synergistic anti-tumour activity of sorafenib in combination with pegylated resveratrol is mediated by Akt/mTOR/p70S6k-4EBP-1 and c-Raf7MEK/ERK signaling pathways
by: Ligang Wang, et al.
Published: (2023-08-01)

Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
by: Vincenzo Sorrenti, et al.
Published: (2022-07-01)

Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
by: Tarek El-Sewedy, et al.
Published: (2023-09-01)

Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer
by: Bhurichaya Innets, et al.
Published: (2022-11-01)

UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
by: Junyi Wu, et al.
Published: (2023-09-01)

A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR
by: Runjie Song, et al.
Published: (2023-01-01)

Substituents introduction of methyl and methoxy functional groups on resveratrol stabilizes mTOR binding for autophagic cell death induction
by: Zin Zin Ei, et al.
Published: (2025-04-01)

Ellagic acid inhibits tumor growth and potentiates the therapeutic efficacy of sorafenib in hepatocellular carcinoma
by: Zhenju Tan, et al.
Published: (2024-01-01)

Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells
by: J.Y. Cao, et al.

Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma
by: Ruiqi Zheng, et al.
Published: (2023-01-01)

Resveratrol attenuates staphylococcal enterotoxin B-activated immune cell metabolism via upregulation of miR-100 and suppression of mTOR signaling pathway
by: Hasan Alghetaa, et al.
Published: (2023-02-01)

The HIF-1α and mTOR Pathways Amplify Heterotopic Ossification
by: Haitao Wang, et al.
Published: (2024-01-01)

Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
by: Agnieszka Karbownik, et al.
Published: (2020-06-01)

Mechanism of sorafenib resistance associated with ferroptosis in HCC
by: Lingling Guo, et al.
Published: (2023-06-01)

Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01)

Resveratrol Induces Myotube Development by Altering Circadian Metabolism via the SIRT1-AMPK-PP2A Axis
by: Natalie Avital-Cohen, et al.
Published: (2024-06-01)

Folic Acid-Targeted Liposome-Based Nanoparticle Loaded with Sorafenib for Liver Cancer Therapy
by: Liu S, et al.
Published: (2025-03-01)

Local intra-articular injection of resveratrol delays cartilage degeneration in C57BL/6 mice by inducing autophagy via AMPK/mTOR pathway
by: Na Qin, et al.
Published: (2017-07-01)

CXCR4-guided liposomes regulating hypoxic and immunosuppressive microenvironment for sorafenib-resistant tumor treatment
by: Yuehua Wang, et al.
Published: (2022-11-01)

Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats
by: Agnieszka Karbownik, et al.
Published: (2021-12-01)

Advances in the regulatory mechanisms of mTOR in necroptosis
by: Yawen Xie, et al.
Published: (2023-12-01)

Dual-targeting liposomal delivery of sorafenib and docetaxel for enhanced synergistic therapy in advanced hepatocellular carcinoma
by: Yawen Yao, et al.
Published: (2024-12-01)

UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF‐1α signaling
by: Cailu Song, et al.
Published: (2024-02-01)

Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1α signaling pathway
by: Jing Yang, et al.
Published: (2023-11-01)

Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma
by: Yao Yao, et al.
Published: (2019-12-01)

Resveratrol mitigates cadmium chloride-induced cardiotoxicity in rats via AMPK-mediated signaling: The modulatory role of low-dose gamma radiation
by: Nermeen M. El Bakary, et al.
Published: (2025-09-01)

Cryptotanshinone increases the sensitivity of liver cancer to sorafenib by inhibiting the STAT3/Snail/epithelial mesenchymal transition pathway
by: Li Zhiyu, et al.
Published: (2022-05-01)

Antitumor activity of sorafenib on colorectal cancer
by: Turgut Kacan, et al.
Published: (2016-08-01)

Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy
by: Jie Wei, et al.
Published: (2016-12-01)

Triclosan-induced glycolysis drives inflammatory activation in microglia via the Akt/mTOR/HIF 1α signaling pathway
by: Jieyu Liu, et al.
Published: (2021-11-01)

Modulation of the mTOR Pathway by Curcumin in the Heart of Septic Mice
by: Bruna A. C. Rattis, et al.
Published: (2022-10-01)

Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib
by: Ki-Young Huh, et al.
Published: (2021-04-01)

Exploring the role of mTOR pathway in aging and age-related disorders
by: Komal Raghuvanshi, et al.
Published: (2025-08-01)

Resveratrol Ameliorates High Altitude Hypoxia-Induced Osteoporosis by Suppressing the ROS/HIF Signaling Pathway
by: Changqing Yan, et al.
Published: (2022-08-01)

Resveratrol induces autophagy-dependent apoptosis in HL-60 cells
by: Yingying Fan, et al.
Published: (2018-05-01)

Anti-proliferative effects of paroxetine alone or in combination with sorafenib in HepG2 cells
by: Yaprak Donmez Cakil, et al.
Published: (2023-01-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01)

The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
by: Letizia Todeschini, et al.
Published: (2023-06-01)

The Combination Therapy With Sorafenib in Therapeutic Strategy of Acute Myeloid Leukemia. Is It Promising? A Narrative Review
by: Mobina Nakhaei Shamahmood, et al.
Published: (2025-10-01)

Enhanced anti-tumor therapy for hepatocellular carcinoma via sorafenib and KIAA1199-siRNA co-delivery liposomes
by: Yao Yao, et al.
Published: (2024-09-01)